Practice Tip: Educate patients on the link between poor sleep and dry eye
In her article, “Educating patients on dry eye disease prevention,” Lisa Hornick, OD, MBA, FAAO, discusses the importance of educating patients on the connection between poor sleep and dry eye disease (DED): “…It is essential we inquire with patients about their quality/duration of sleep, as well as discuss with them the importance of getting good, quality sleep, so they can prevent DED,” she writes. Studies included. Read more.

Balance Ophthalmics glaucoma therapy receives denovo classification
Balance Ophthalmics announced that the FDA has granted De Novo classification of its FYSX Ocular Pressure Adjusting Pump. The pump is a non-pharmacological, non-surgical, during-sleep treatment designed to lower IOP in patients who have normal tension glaucoma and open-angle glaucoma with IOP ≤21 mm Hg.

Bausch + Lomb shares results from inaugural State of Dry Eye survey
Bausch + Lomb’s inaugural “State of Dry Eye” survey, which explores dry eye disease (DED) understanding and experiences among American adults, revealed the following highlights:

• DED impacts quality of life. Three in four sufferers say they find dry eye extremely or very bothersome, with three in 10 saying that their symptoms have worsened over time.
• DED makes it difficult to enjoy day-to-day activities. Most sufferers (67%) say they had to give up or cut back on something to relieve symptoms, including screen time (32%), spending time outdoors (25%), and wearing makeup (24%).
• DED is not widely known. Most Americans say they don’t know much about the condition, what to do about it or that their symptoms may be associated with DED. Additionally, most (70%) say they don’t know much about preventing or treating the condition.

Euclid to host Ortho-K troubleshooting webinar
Euclid is hosting the webinar “Making a U-Turn When Things Go South: A Common Sense Guide to Ortho-K Troubleshooting,” on July 30. According to a press release, attendees will:

• Gain insights into the specific criteria used to define a successful orthokeratology fitting, including key parameters and adjustment strategies. 
• Master the art of effective communication with lens consultants, including acquisition of data and pertinent questions to ask and understand for seamless collaboration.
• Enhance their skills in capturing and interpreting corneal topography images with best practices to optimize fitting outcomes.
  Register here.

Harrow enters vendor program contract
Harrow entered into an agreement to make chloroprocaine hydrochloride ophthalmic gel 3% (Iheezo), moxifloxacin hydrochloride ophthalmic solution 0.5% (Vigamox), and nepafenac ophthalmic suspension 0.3% (Ilevro) available through the Apexus 340B Prime Vendor Program.

HOYA presents myopia data at EURETINA
HOYA Vision Care presented myopia data at the first EURETINA Special Focus Meeting, held in Paris, in June. “Confidence through evidence – MiYOSMART in daily practice,” presented by HOYA Vision Care, was a session to raise awareness among eye care practitioners on the importance of choosing appropriate myopia management solutions, supported by safety and effectiveness, and highlight MiYOSMART, a spectacle lens solution for myopia. MiYoSMART is not approved for myopia management in the United States.

International Agency for the Prevention of Blindness launches 2024 World Sight Day campaign
The International Agency for the Prevention of Blindness (IAPB) launched the World Sight Day campaign for World Sight Day, which occurs Oct. 10. This year’s campaign features Artie, the World Sight Day mascot, a suite of eye health activities pages and learning materials designed for children of all ages that can be accessed via the IAPB website, and the “Glasses of the Future” competition, which invites children to color and invent the next generation of glasses. For more information and to get involved, read more  

Ocuco to host webinar on strategies to improve online presence and patient experience
Ocuco is hosting the webinar “Enhancing Patient Experience Through Online Eyecare Services” on Tuesday, July 16, from 5:30 p.m. to 6:30 p.m., PDT. The webinar will cover optical case studies to showcase various strategies eye care businesses are employing to improve their online presence and patient experience. The webinar is presented by Dr. Harbir Sian, a Ted Talk speaker and optometrist, and Paul Clare, OptiCommerce founder. Register here.

Ocular Therapeutix to present study abstract on non-proliferative diabetic retinopathy treatment
Ocular Therapeutix, Inc. announced it will present an abstract related to its Phase 1 study of axitinib intravitreal implant (Axpaxi) for non-proliferative diabetic retinopathy at the 42^nd American Society of Retina Specialists Annual Scientific Meeting, occuring July 17 to July 20, in Stockholm, Sweden. The abstract is titled “Interim Safety and Efficacy Results From the Phase 1 HELIOS Trial of Sustained-release Axitinib Implant (OTX-TKI) for NPDR.”

Ophthea Limited announces publication of scientific review therapies for wet AMD
“Vascular Endothelial Growth Factor (VEGF) C and D Signaling Pathways as Potential Targets for the Treatment of Neovascular (Wet) AMD” was published in Ophthalmology and Therapy. The scientific review supports the scientific rationale for sozinibercept (OPT-302; Ophthea Limited) as a potential treatment for wet AMD. Read more

Scope Eyecare & Healthcare launches eye-friendly makeup remover
Scope Eyecare & Healthcare launched Optase Life Sensitive Eye Makeup Remover to meet the needs of those with sensitive eyes, according to a press release. It contains hyaluronic acid, provitamin B5, and Manuka honey.

Tear Film & Ocular Surface Society accepting abstracts for fall meeting
The Tear Film & Ocular Surface (TFOS) board of directors is welcoming submissions of abstracts for the 10^th International TFOS Conference on the Tear Film & Ocular Surface: Basic Science and Clinical Relevance. The meeting is occurring Oct. 30 to Nov. 2 in Venice, Italy. Abstract submission is open through Aug. 2. Follow the link to learn more.

Thea Pharma unveils resources for Iyuzeh
Thea Pharma launched resources for eye care professionals to provide to its patients who use Iyuzeh. The website offers a variety of instructions, visuals, and downloads. 

Transitions Optical accepting applications for educational grants
Transitions Optical, Inc., in partnership with its Diversity Advisory Board, is now accepting applications for its inaugural Diversity in Optical educational grant program through Aug. 31 at 11:59 p.m. EDT. Specifically, Transitions Optical will award five $1,000 grants to applicants graduating high school and seniors aspiring to attend opticianry school in the United States. Additionally, two $5,000 grants will be awarded to second-year optometry or ophthalmology students attending an accredited U.S. school or college. Read more.

WaveRFID and Crystal Practice Management announce integration
WaveRFID and Crystal Practice Management announced the integration of WaveRFID’s RFID technology with Crystal Practice Mangement’s inventory data. Specifically, the RFID technology can scan more than 1,000 items in less than 10 minutes, enhancing operational efforts and enabling practitioners to focus more on delivering quality patient care, according to a press release. Read more.